Hormone Therapy, Explained: Everything You Need to Know After the FDA Decision

This Perry Academy webinar replay features OB GYN and menopause expert Dr. Robin Noble unpacking the FDA’s recent decision to remove the black box warning from hormone therapy. Designed for prescribers and allied health professionals, the session provides clear, evidence based context on what changed, why it matters, and how clinicians should update real world risk benefit conversations.


The course covers vaginal and systemic estrogen, differences between estrogen types and delivery methods, implications for breast cancer and cardiovascular risk, mental health, joint pain, weight management, and early menopause. Emphasis is placed on nuance, shared decision making, and individualized care rather than one size fits all guidance.


Participants leave with practical clarity on how to counsel patients confidently, address common misconceptions rooted in the WHI era, and apply current evidence to perimenopause and menopause care in everyday clinical practice.

  • Instructors

    Robin Noble, MD

  • 1h 04min

    Video duration

  • Interactive Webinar Replay

    Course Instructor
    Robin Noble, MD, MHCDS, MSCP
    OBGYN
    • Board Certified OB/GYN (FACOG)
    • Fellowship Trained in Minimally Invasive Gynecologic Surgery
    • Certified Menopause Provider (MSCP)
    • Chief Medical Advisor: Let’s Talk Menopause
    • Boarded in Lifestyle Medicine (Dip ABLM)
    • Masters in Health Care Science Delivery
    • 25 years of Clinical Practice
    • Physician owned multi specialty group in Portland, Maine

    Lesson series

    Stay certified. Stay current.

    This and many more courses, resources, live events and case studies are part of an active Perry Academy Membership.

    Become a Perry Academy member for ongoing education, events, and CE access to a growing library—all year long
    Write your awesome label here.